Informação do artigo
O texto completo está disponível em PDF
References
[1]
Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med. 1976;295:526-9.
[2]
M.A. Heymann, A.M. Rudolph, N.H. Silverman.
Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.
N Engl J Med., 295 (1976), pp. 530-533
[3]
Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD. Ibuprofen treatment of patent ductus arteriosus. Lancet. 1995;346:255.
[4]
Dani C, Vangi V, Bertini G, Pratesi S, Lori I, Favelli F, et al. High- dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clin Pharmacol Ther. 2012;91:590-6.
[5]
Yang E, Song ES, Choi Y. Comparison of oral ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in extremely low birth weight infants. J Pediatr (Rio J). 2013;89:33-9.
[6]
Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2012; 97:F279-83.
[7]
Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kelishadi R. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi. 2007;9:399-403.
[8]
H. Aly, W. Lotfy, N. Badrawi, M. Ghawas, I.E. Abdel-Meguid, T.A. Hammad.
Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study.
Am J Perinatol., 24 (2007), pp. 267-270
[9]
Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai. 2003;86: S563-9.
[10]
Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai. 2002;85:S1252-8.
[11]
Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics. 2003;112:e354.
[12]
Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr. 2011;158:549-54.
[13]
Barzilay B, Youngster I, Batash D, Keidar R, Baram S, Goldman M, et al. Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2012; 97:F116-9.
[14]
Hammerman C, Shchors I, Jacobson S, Schimmel MS, Bromiker R, Kaplan M, et al. Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration? Pediatr Res. 2008; 64:291-7.
[15]
K. de Waal, M. Kluckow.
Functional echocardiography; from physiology to treatment.
Early Hum Dev., 86 (2010), pp. 149-154
Ferramentas
Artigos
recomendados
recomendados
J Pediatr (Rio J). 2020;96:614-20
Publicar em
Jornal de Pediatria
Edição nº 1
Faça o download da edição nº1 do Jornal de Pediatria, de 1934
Ano
1934
Jornal do Pediatria nº1
